Skip to main content
Back
Watch Compare

PMV Pharmaceuticals, Inc.

Data quality: 83%
PMVP
NASDAQ Manufacturing Chemicals
$1.32
▼ $0.01 (-0.75%)
Mkt Cap: 70.66 M
Price
$1.33
Mkt Cap
70.66 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -73.61 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-59.43%
Below sector avg (-54.47%)
ROIC-51.83%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio10.76
Interest Coverage-13.60

Valuation

PE (TTM|NTM)
-0.91 | -1.20
Above sector avg (-1.49)
P/B Ratio0.58
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1385 peers)
Metric Stock Sector Median
P/E -0.9 -1.5
P/B 0.6 1.6
ROE % -59.4 -54.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.9
D/E — 0.3

Analyst Price Target

4 analysts
Buy
Current
$1.32
+487.1%
Target
$7.75
$4.00
$5.50
$16.00
Forecast
Forward P/E -1.20
Forward EPS -$1.10
Est. Revenue 2.97 M

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$1.10
-$1.22 – -$0.94
 2.97 M 3
FY2026 -$1.60
-$1.64 – -$1.55
 0.0 2

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$0.40 -$0.34 +13.9%
Q32025 -$0.40 -$0.40 +0.6%
Q22025 -$0.39 -$0.41 -6.5%
Q12025 -$0.38 -$0.34 +11.3%

ETFs Holding This Stock

BRUSX BRUSX
0.46% weight
MISGX MISGX
0.41% weight
MSGAX MSGAX
0.41% weight
MSGRX MSGRX
0.41% weight
MSGCX MSGCX
0.41% weight
MSGGX MSGGX
0.41% weight
BRSIX BRSIX
0.06% weight
BDSCX BDSCX
0.01% weight
BDSKX BDSKX
0.01% weight
BDSAX BDSAX
0.01% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -77.74 M
ROE -59.43% ROA -54.23%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -73.61 M
ROIC -51.83% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 10.76
Interest Coverage -13.60 Asset Turnover N/A
Working Capital 120.15 M Tangible Book Value 121.00 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.91 Forward P/E -1.20
P/B Ratio 0.58 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 23.77 Fwd Earnings Yield N/A
FCF Yield -104.17%
Market Cap 70.66 M Enterprise Value 34.32 M
Per Share
EPS (Diluted TTM) -1.48 Revenue / Share N/A
FCF / Share -1.38 OCF / Share -1.38
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 94.68%
SBC-Adj. FCF -80.78 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -77.74 M -58.71 M -68.96 M -73.32 M -57.85 M
EPS (Diluted) -1.48 -1.14 -1.44 -1.61 —
Gross Profit — — — — —
Operating Income -86.21 M -85.45 M -80.13 M -77.04 M -58.29 M
EBITDA — — — — —
R&D Expenses 69.88 M 58.53 M 55.89 M 51.99 M 36.49 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 6.34 M 10.66 M 11.17 M 3.63 M 449,000.0
Income Tax -2.17 M -16.10 M 2,000.0 -9,000.0 23,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 116.56 M 191.29 M 252.15 M 270.31 M 331.57 M
Total Liabilities 11.85 M 15.21 M 26.46 M 24.28 M 23.01 M
Shareholders' Equity 104.71 M 176.08 M 225.69 M 246.03 M 308.56 M
Total Debt — — — — —
Cash & Equivalents 37.98 M 40.88 M 37.71 M 108.30 M 172.47 M
Current Assets 115.23 M 175.66 M 207.41 M 247.01 M 301.29 M
Current Liabilities 11.42 M 14.37 M 14.03 M 10.83 M 12.22 M